Medicare Enrolled

Dr. Peter Rosenblatt, MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Cambridge, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
725 CONCORD AVE, Cambridge, MA 02138
6173545452
In practice since 2006 (20 years)
NPI: 1629048665 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenblatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenblatt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosenblatt

Dr. Peter Rosenblatt is an urogynecology and reconstructive pelvic surgery physician in Cambridge, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rosenblatt performed 3,849 Medicare services across 909 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosenblatt received a total of $291,054 from 44 pharmaceutical and/or device companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosenblatt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 24% volume in MA $291,054 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,849
Medicare services
Top 24% in MA for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
909
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~192 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
2,800 $5 $8
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
331 $9 $91
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
166 $71 $233
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $106 $331
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
113 $3 $11
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
98 $137 $374
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
66 $11 $137
Urethral sling procedure for female incontinence
A surgical procedure that creates a supportive sling around the urethra to help control urinary leakage in women.
26 $446 $1,701
Cystoscopy with chemical ablation of bladder
A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue.
25 $355 $762
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
22 $197 $537
Vaginal defect repair using endoscope
A surgical procedure to repair a defect in the vagina using an endoscope, which is a thin, lighted tube inserted into the body to visualize the area.
22 $793 $2,432
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
21 $35 $218
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $21 $45
Laparoscopic removal of ovaries and/or fallopian tubes
A surgical procedure to remove one or both ovaries and/or fallopian tubes using a small camera and instruments inserted through tiny incisions in the abdomen.
15 $355 $1,779
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
81.3% medium
18.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$291,054
Total received (2018-2024)
Avg $41,579/year across 7 years
Top 0% in MA for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
711
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$206,503 (70.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$54,937 (18.9%)
Other
Charitable contributions, space rental, and other categories
$18,333 (6.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,282 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,278
2023
$26,502
2022
$28,104
2021
$39,907
2020
$31,688
2019
$81,537
2018
$71,038

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$7,133
COLOPLAST CORP
$3,640
ABBVIE INC.
$400
Medtronic, Inc.
$370
Axonics, Inc.
$352
Sumitomo Pharma America, Inc.
$214
Astellas Pharma US Inc
$62
Laborie Medical Technologies Corp.
$46
Hologic Sales and Service, LLC
$45
Minerva Surgical, Inc
$17
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$79,940
Medtronic USA, Inc.
$46,483
Coloplast Corp
$45,033
BOSTON SCIENTIFIC CORPORATION
$39,325
Davol Inc.
$18,333
Medtronic, Inc.
$17,060
CooperSurgical, Inc.
$14,032
COLOPLAST CORP
$11,264
Hologic, LLC
$6,141
Stryker Corporation
$3,500
Axonics, Inc.
$2,147
Astellas Pharma US Inc
$1,175
Caldera Medical, Inc
$1,115
ABBVIE INC.
$616
Cytyc Surgical Products, LLC
$520
Allergan, Inc.
$512
PFIZER INC.
$472
AbbVie Inc.
$428
Integra LifeSciences Corporation
$420
Gynesonics, Inc.
$334
Sumitomo Pharma America, Inc.
$260
TherapeuticsMD, Inc.
$259
Renovia Inc
$257
UROCURE LLC
$189
Allergan Inc.
$179
AbbVie, Inc.
$173
Laborie Medical Technologies Corp.
$145
Myovant Sciences Inc.
$96
UROVANT SCIENCES INC
$94
Intuitive Surgical, Inc.
$79
Minerva Surgical, Inc
$72
180 Medical, Inc.
$53
Applied Medical Resources Corporation
$50
ConvaTec Inc.
$49
Hologic Sales and Service, LLC
$45
Aesculap, Inc.
$40
Ethicon US, LLC
$37
Rochester Medical Corporation
$24
ROCHESTER MEDICAL CORPORATION
$24
AMAG Pharmaceuticals, Inc.
$18
Lupin Inc.
$17
HOLOGIC INC
$16
Metuchen Pharmaceuticals
$14
LSI SOLUTIONS INC
$12
Top 3 companies account for 58.9% of all-time payments
Associated products mentioned in payments ›
1688 · ACESSA PROVU SYSTEM · ADVANTAGE · ADVANTAGE FIT · ALTIS · Advantage System · Altis · Axonics · BOTOX · BOTOX - UROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · Biozorb · Bulkamid · CAIMAN VESSEL SEALERS · CROSSBOSS · CoolSeal Generator · Da Vinci Surgical System · Desara · ESTRING · Eclipse · Endosee · Equipment · FEMALE INCONTINENCE · FORNISEE · GEMTESA · GENERAL PELVIC ORGAN PROLAPSE · GENERAL THERAPIES · GENERAL - FEMALE SUI · GENERAL - PELVIC ORGAN PROLAPSE · GENERAL - THERAPIES · GENERAL FEMALE SUI · GENERAL PELVIC ORGAN PROLAPSE · GENERAL THERAPIES · GENTLECATH · GYN Office Instrumental · General - Pelvic Organ Prolapse · GentleCath · Hospital Instrumentation · IMVEXXY · INTERSTIM · INTRAROSA · Integra · Leva Pelvic Floor Trainer · LigaSure · Lone Star · Lupron · MYFEMBREE · MYOSURE TISSUE REMOVAL DEVICE · MYRBETRIQ · MyoSure · Myrbetriq · NOVASURE · Orilissa · PREMARIN · PVC · Pelvic Health · RESTORELLE · SENSOR · SOLOSEC · SOLYX · SOLYX BLUE · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · STRATAFIX · SUPRIS · SYMPHION · Saffron · Signia · Solyx SIS System · Stendra · THERAPIES · TITAN · UPHOLD LITE · UPSYLON · Upsylon · Uterine Manipulators & Injectors · Veozah · leva Pelvic Floor Trainer
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in MA.

Looking for an urogynecology and reconstructive pelvic surgery physician in Cambridge?
Compare urogynecology and reconstructive pelvic surgery physicians in the Cambridge area by procedure volume, costs, and industry payment transparency.
Browse urogynecology and reconstructive pelvic surgery physicians nearby

Geographic Context

Urogynecology and reconstructive pelvic surgery physicians within 10 mi
12
Per 100K population
0.7
County median income
$126,779
Nearest hospital
MOUNT AUBURN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosenblatt is a mixed practice specialist, with above-average Medicare volume (top 24% in MA), with speaking/promotional industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosenblatt experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rosenblatt performed 2,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenblatt receive payments from pharmaceutical companies?
Yes. Dr. Rosenblatt received a total of $291,054 from 44 companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenblatt's costs compare to other urogynecology and reconstructive pelvic surgery physicians in Cambridge?
Dr. Rosenblatt's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenblatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →